John Boyle, MD
Ophthalmology · Metairie, LANPI 1225177009
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 281 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,772, 2.3 times the $760 reported in 2019.
Across 281 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Johnson & Johnson Surgical Vision, Inc.$715
- Glaukos Corporation$544
- AbbVie$523
- Tarsus Pharmaceuticals, Inc.$517
- Rxsight Inc$411
- plus $3K from 21 others
What the payments were for
- Food & beverage$7,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 59 | $1,562 |
| Johnson & Johnson Surgical Vision, Inc. | 19 | $715 |
| Glaukos Corporation | 10 | $544 |
| AbbVie(2 entities) | 38 | $523 |
| Tarsus Pharmaceuticals, Inc. | 32 | $517 |
| Rxsight Inc | 5 | $411 |
| Ivantis, Inc | 4 | $405 |
| Oyster Point Pharma, Inc. | 13 | $324 |
| Mallinckrodt Hospital Products Inc. | 12 | $314 |
| Dompe US, Inc. | 9 | $234 |
| Bausch & Lomb Americas Inc. | 14 | $227 |
| Carl Zeiss Meditec USA, Inc. | 1 | $206 |
| Sun Pharmaceutical Industries Inc. | 10 | $181 |
| Biotissue Holdings Inc. | 9 | $150 |
| Ocular Therapeutix, Inc. | 7 | $114 |
| Eyevance Pharmaceuticals LLC | 8 | $113 |
| Sight Sciences, Inc. | 6 | $109 |
| Heidelberg Engineering, Inc. | 3 | $72 |
| Aerie Pharmaceuticals, Inc. | 4 | $68 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $67 |
| Rayner Intraocular Lenses Limited | 4 | $62 |
| Harrow Eye, LLC | 2 | $47 |
| NEW World Medical,inc. | 3 | $37 |
| Coopervision Inc. | 2 | $30 |
| Novartis | 1 | $30 |
| Beaver-visitec International, Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hydrus Microstent$437
- RXSIGHT CONTACT LENS$376
- RXSIGHT INJECTOR CARTRIDGE$376
- RXSIGHT INJECTOR HANDPIECE$376
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$376
- AcrySof$261
- LIGHT ADJUSTABLE LENS (LAL)$255
- CIRRUS 5000$206
- iDoseTR$187
- Clareon PanOptix Pro$138
- Tecnis Simplicity$125
- XDEMVY$122
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$122
- iDose$115
How this compares
$7,102 in reported general payments places this provider in the 85th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RocklatanNetarsudil Mesylat/Latanoprost | 281 | $124,033 |
| LumiganBimatoprost | 202 | $68,574 |
| RestasisCyclosporine | 82 | $67,018 |
| CombiganBrimonidine Tartrate/Timolol | 222 | $66,183 |
| XdemvyLotilaner | 31 | $58,504 |
| RhopressaNetarsudil Mesylate | 108 | $43,051 |
| TyrvayaVarenicline Tartrate | 41 | $29,206 |
| Latanoprost | 2,403 | $18,518 |
| Alphagan PBrimonidine Tartrate | 50 | $17,564 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 62 | $16,399 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 1,062 | $15,787 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 138 | $15,691 |
| XiidraLifitegrast | 23 | $15,367 |
| Prednisolone Acetate | 480 | $14,435 |
| IlevroNepafenac | 32 | $12,063 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan, Alphagan P | $523 | $219,339556 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $68 | $167,083389 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $517 | $58,50431 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $324 | $29,20641 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $227 | $24,07849 claims |
| AlconSimbrinza | $1,562 | $16,39962 claims |
| NovartisIlevro | $30 | $12,06332 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Loteprednol Etabonate | $67 | $8,09031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 286 ophthalmology providers in Louisiana.
Other ophthalmology in Metairie
- Ethan SternMetairie$16K
- John FrisbeeMetairie$14K
- Benjamin GuidryMetairie$9K
- Scott LanouxMetairie$8K
- Tyler GoffMetairie$7K
- Nicholas FrisardMetairie$7K
- Brandon DavisMetairie$7K
- Henry HaleyMetairie$7K
- Owen LacourMetairie$6K
- Joshua GroetschMetairie$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.